Is Bio-adrenomedullin (Bio-ADM) a Prognostic Factor in Patients With COVID-19 Treated in the ICU?

NCT04813939 · clinicaltrials.gov ↗

TERMINATED

Status

32

Enrollment

OTHER

Sponsor class

Stopped Enrollment was terminated because of the poor recruitment rate.

Conditions

Covid19

Interventions

DEVICE: IB10 sphingotest® bio-ADM® apparatus (Sphingotec GmbH, Hennigsdorf, Germany)

Sponsor

Medical University of Warsaw